Best in Germany: UBS
Structured Products Europe Awards 2015: UBS has maintained its position as a leading foreign issuer in many sectors, while focusing on delivering capital savings for insurers through equity portfolio optimisation ahead of Solvency II
On January 22, the European Central Bank unveiled a massive quantitative easing programme amounting to €60 billion ($67 billion) a month. Then on February 25, Germany decided to sell five-year government bonds at negative yields for the first time. Those two events, both of which highlighted the fragility of the economic recovery in Europe, acted as a catalyst to force investors to consider low-volatility equity strategies as an alternative to fixed income.
UBS has been at the forefront of catering to this shift and boosted its activity in Germany over the past year, even though, as a foreign issuer, the bank lacks the captive distribution network of domestic German banks.
The bank has maintained a market share of 8% in public distribution so far this year, according to data from Deutsche Börse's Boega system analysed by Switzerland-based Technolab Informatik. UBS is also the largest foreign issuer of income-generating equity structures such as autocallable express certificates and reverse convertible notes sold to intermediaries, with a market share of 9%. Its position was bolstered by its having transacted a notional value of €636 million in equity-linked products so far in 2015, up from €419 million in 2014.
"UBS is in the top three issuers for us," says a Frankfurt-based wealth management specialist. "The bank's offering is very broad and they are very innovative with their solutions. If there is an opportunity in the market, they contact us and they know what we are able to do with our clients. As soon as we have an exotics request from a client, UBS is normally one of our first points of call for ideas."
Elsewhere, UBS has a market share of roughly 10% in the secondary trading of income certificates on its platforms, offering around 4,000 products and posting a turnover of more than €130 million over the year.
There is a developing theme to shift out of pure equity portfolios into funds with a volatility overlay
The bank has also focused on marketing options strategies in equity portfolios that will enable insurers to lower their capital charges once Solvency II comes into force at the start of 2016. The process began with a series of roadshows to brief both insurance companies and asset managers last year, and UBS boasts a specialist team that concentrates on Solvency II compatible equity structures.
While equities typically amount to no more than 10% of insurers' asset allocation, companies are looking for capital relief wherever they can find it, says Andres Schmitz, head of derivatives distribution for Germany, Austria and the Netherlands at UBS. "There are some quite easy wins in equities. While insurers have focused on optimising fixed-income holdings they are looking at this aspect now, especially if they wish to benefit from lower charges in the transition period. It still makes a difference if you can reduce your capital charge," he says.
UBS has already executed hedges with insurers with a notional value of several billion euros, varying from vanilla put options to more complex hedging solutions such as limited recourse leveraged structures. In one instance, the bank constructed a restrike put option, giving the client the discretion to reset a put in the event of a market rally to avoid higher capital charges. Otherwise, if the put strike price remains at the same level, capital requirements would increase as the underlying asset rallies.
"There is a developing theme to shift out of pure equity portfolios into funds with a volatility overlay. You can reduce your capital holding requirements for the instruments from 39% of the value down to 20%, and that's what we're aiming for," says Schmitz.
In addition to the overlays, UBS has conducted in-depth studies on the use of synthetic equity investments, mainly in long-dated call options. Because of their embedded time value, long-dated call options retain value when subjected to Solvency II stress parameters. However, the fixed strike means the capital charges can increase if the underlying equity rallies significantly. As a result, lock-in features can be included in the option to reduce such charges.
Munich-based insurer WWK Group started equity portfolio optimisation with UBS at the end of 2013 and Michael Stoerzinger, risk manager at the company, remains pleased with the relationship ahead of the new regulatory regime.
"UBS was the most attractive partner for us," said Stoerzinger. "Every month we get a new wave of client payments that needs to be hedged and we are very happy with our deal with UBS and the procedure we use to optimise our positions. We are in direct contact with the bank once each month to update the portfolios."
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact info@risk.net to find out more.
You are currently unable to copy this content. Please contact info@risk.net to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@risk.net
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@risk.net
More on Awards
Best execution product of the year: Tradefeedr
Tradefeedr won Best execution product of the year for its API platform, which standardises and streamlines FX trading data, enabling better performance analysis and collaboration across financial institutions
Collateral management and optimisation product of the year: LSEG Post Trade
LSEG Post Trade wins Collateral management and optimisation product of the year for interconnected services that help mitigate counterparty risk and optimise capital usage
Clearing house of the year: LCH
Risk Awards 2025: LCH outshines rivals in its commitment to innovation and co-operation with clearing members
Driving innovation in risk management and technology
ActiveViam secured three major wins at the Risk Markets Technology Awards 2025 through its commitment to innovation in risk management and technology
Regulatory reporting product of the year: Regnology
Regnology retains its award for Regulatory reporting product of the year at this year’s Risk Markets Technology Awards.
Electronic trading support product of the year: TransFICC
TransFICC’s One API and automation solutions earned the Electronic trading support product of the year award by tackling fragmentation and streamlining workflows in fixed income and derivatives markets
Market data vendor of the year: S&P Global Market Intelligence
S&P Global Market Intelligence wins Market data vendor of the year for its comprehensive data solutions and tools supporting trading, risk management and compliance
Best use of machine learning/AI: CompatibL
CompatibL’s groundbreaking use of LLMs for automated trade entry earned the Best use of machine learning/AI award at the 2025 Risk Markets Technology Awards, redefining speed and reliability in what-if analytics